Related Experiment Videos
Seminal 'priming' for protection from pre-eclampsia-a unifying hypothesis
Sarah A Robertson1, John J Bromfield, Kelton P Tremellen
1Department of Obstetrics and Gynaecology, Adelaide University, SA 5005 Adelaide, Australia. sarah.robertson@adelaide.edu.au
Journal of Reproductive Immunology
|August 5, 2003
Summary
Insemination activates maternal immune responses, contrary to prior beliefs. Semen, particularly transforming growth factor beta (TGFbeta), promotes immune tolerance, enhancing fetal development and potentially preventing pre-eclampsia.
Area of Science:
- Reproductive Immunology
- Maternal-Fetal Tolerance
Background:
- Conventional views suggested immune responses to ejaculate antigens hinder fertilization and pregnancy.
- Emerging evidence indicates insemination positively influences reproductive events by activating maternal immune mechanisms.
Purpose of the Study:
- To review the experimental basis for the positive role of insemination in reproduction.
- To hypothesize that TGFbeta-induced immune hypo-responsiveness explains the protective effect of insemination in pre-eclampsia.
Main Methods:
- Review of experimental data on immune responses to ejaculate antigens.
- Focus on the role of transforming growth factor beta (TGFbeta) in seminal plasma.
- Analysis of lymphocyte activation and hypo-responsiveness in draining lymph nodes.
Main Results:
- Semen triggers antigen-presenting cell influx and lymphocyte activation in the female reproductive tract.
- Transforming growth factor beta (TGFbeta) initiates inflammation and immune deviation, reducing Type-1 bias.
- Prior exposure to semen is linked to enhanced fetal-placental development.
Conclusions:
- Insemination actively modulates the maternal immune system to support pregnancy.
- TGFbeta is a key mediator of immune tolerance to paternal antigens.
- This immune tolerance may underlie the protective effect of insemination against pre-eclampsia in women.